AZTR

Azitra Inc

0.18 USD

Last updated Sep 5, 11:24 UTC

Yesterday HIGH

$0.18

Yesterday LOW

$0.17

52w HIGH

$1.09

52w LOW

$0.1

EPS

-0.17

PE

-1.05

Next Earnings

Nov 11, 2026

Overview News Government Trades Fundamentals

Azitra Inc stock is up 37.35% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 September’s closed higher than August.

Benzinga Insights

Tue Jun 23, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to $2.28. The
Benzinga Insights

Mon Jun 22, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to $0.02.
Avi Kapoor

Mon Jun 22, 2026

Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket

SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth in 2026. Other gainers include EHGO, GETY, TNON, AZTR, CDT, APGE, ADTX, MLTX, and SYRE. Losers include AIXI, GPUS, NIPG, and LICN.
Mohd Haider

Fri Jun 19, 2026

Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?

Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and upcoming biotech presentation plans.
Benzinga Insights

Thu Jun 18, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Newsdesk

Wed Jun 17, 2026

Azitra shares are trading higher after it announced it's pursuing new commercial opportunities in cosmetic skincare and leveraging its platform to explore broader applications in biotech products and recombinant proteins. Also, the CEO expects the programs will be in a position to be partnered or commercialized in the next 36 months.
Benzinga Newsdesk

Wed Jun 17, 2026

Azitra To Pause Further Enrollment In ATR-12 Trial To Redirect Funds To ATR-COSF

New Initiatives:ATR-COSF: Expansion into Cosmetic IngredientsOne of the most exciting initiatives enabled by the March financing is ATR-COSF, a recombinant filaggrin protein program designed for the cosmetic ingredient
Benzinga Insights

Wed Jun 17, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights

Wed Jun 10, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Newsdesk

Wed May 13, 2026

Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate

Anitra (AMEX:AZTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 83.87 percent increase over losses of $(1.55) per share from the same